Crossmark

Metabolically Healthy Obesity and Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD): Navigating the Controversies in Disease Development and Progression

Crossref DOI link: https://doi.org/10.1007/s13679-025-00637-9

Published Online: 2025-05-19

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Koliaki, Chrysi

Dalamaga, Maria

Kakounis, Konstantinos

Liatis, Stavros
Funding

Funding for this research was provided by:

University of Athens
License Information

Text and Data Mining valid from 2025-05-19

Version of Record valid from 2025-05-19
More Information

Article History

Accepted: 5 May 2025

First Online: 19 May 2025

Declarations

:

: Metabolically healthy obesity and MASLD.

: This article does not contain any studies with human or animal subjects performed by any of the authors.

: The authors declare no competing interests.

Document is current

Any future updates will be listed below